Pacira Change In Cash from 2010 to 2024

PCRX Stock  USD 16.64  0.14  0.83%   
Pacira BioSciences, Change In Cash yearly trend continues to be fairly stable with very little volatility. Change In Cash is likely to outpace its year average in 2024. During the period from 2010 to 2024, Pacira BioSciences, Change In Cash regression line of annual values had r-squared of  0.0002 and arithmetic mean of  12,261,863. View All Fundamentals
 
Change In Cash  
First Reported
2009-09-30
Previous Quarter
63 M
Current Value
-1.1 M
Quarterly Volatility
87.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pacira BioSciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 15.8 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0014 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences, Valuation or Volatility modules.
  
Check out the analysis of Pacira BioSciences, Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Latest Pacira BioSciences,'s Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Pacira BioSciences, over the last few years. It is Pacira BioSciences,'s Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira BioSciences,'s overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Very volatile
   Change In Cash   
       Timeline  

Pacira Change In Cash Regression Statistics

Arithmetic Mean12,261,863
Geometric Mean33,923,992
Coefficient Of Variation1,516
Mean Deviation87,847,357
Median19,464,000
Standard Deviation185,840,532
Sample Variance34536.7T
Range967.1M
R-Value0.01
Mean Square Error37187.3T
R-Squared0.0002
Significance0.96
Slope528,827
Total Sum of Squares483513.8T

Pacira Change In Cash History

202451.6 M
202349.2 M
2022-481.4 M
2021485.6 M
202021.7 M
2019-54.3 M
201878.4 M

About Pacira BioSciences, Financial Statements

Pacira BioSciences, investors use historical fundamental indicators, such as Pacira BioSciences,'s Change In Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Cash49.2 M51.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.